Invesco · 2010-04-07 成立 · 规模、费率、NAV、资金流、完整持仓和风险收益使用各自可追溯公开源。
| 日期 | 估算净流 | 申购 / 销售 | 赎回 | 净资产 | 口径 |
|---|---|---|---|---|---|
| 2026-07-31 | -$3.4M | — | — | $158.7M | 每日估算 |
| 2026-07-27 | +$2.8M | — | — | $161.5M | 每日估算 |
| 2026-07-26 | -$2.8M | — | — | $158.7M | 每日估算 |
| 2026-02-28 | -$3.5M | $872,979 | $4.4M | $139.8M | SEC 月度 |
| 2026-01-31 | -$1.8M | $0 | $1.8M | — |
| 持仓 | 资产类别 | 数量 | 市值 | 权重 |
|---|---|---|---|---|
Invesco Private Prime Fund Invesco Private Prime Fund | STIV | 29,808,249 | $29.8M | 21.33% |
Invesco Private Government Fund Invesco Private Government Fund | STIV | 11,152,021 | $11.2M | 7.98% |
Krystal Biotech, Inc. Krystal Biotech, Inc. | EC | 21,484 | $5.9M | 4.24% |
Glaukos Corp. Glaukos Corp. |
行情与风险截至 2026-07-30；NAV 的发布时间可能和交易所收盘错位。完整持仓是延迟监管披露，不代表当前盘中组合。
已使用：nasdaq_etf_screener、yahoo_chart、yahoo_quote_summary、sec_nport。缺口标记：nav_timestamp_unverified。
| SEC 月度 |
| 2025-12-31 | -$1.8M | $0 | $1.8M | — | SEC 月度 |
| EC |
| 47,811 |
| $5.8M |
| 4.12% |
PTC Therapeutics, Inc. PTC Therapeutics, Inc. | EC | 66,834 | $4.6M | 3.26% |
Protagonist Therapeutics, Inc. Protagonist Therapeutics, Inc. | EC | 48,917 | $4.5M | 3.22% |
Teleflex Inc. Teleflex Inc. | EC | 36,788 | $4.5M | 3.21% |
Alkermes PLC Alkermes PLC | EC | 137,448 | $4.1M | 2.96% |
TransMedics Group, Inc. TransMedics Group, Inc. | EC | 28,448 | $4.1M | 2.96% |
RadNet, Inc. RadNet, Inc. | EC | 57,796 | $4.0M | 2.89% |
BrightSpring Health Services, Inc. BrightSpring Health Services, Inc. | EC | 94,582 | $3.9M | 2.80% |
Merit Medical Systems, Inc. Merit Medical Systems, Inc. | EC | 49,354 | $3.8M | 2.73% |
TG Therapeutics, Inc. TG Therapeutics, Inc. | EC | 113,180 | $3.4M | 2.44% |
Indivior Pharmaceuticals, Inc. Indivior Pharmaceuticals, Inc. | EC | 103,932 | $3.4M | 2.43% |
Ligand Pharmaceuticals Inc. Ligand Pharmaceuticals Inc. | EC | 16,384 | $3.2M | 2.32% |
ICU Medical, Inc. ICU Medical, Inc. | EC | 20,551 | $3.1M | 2.21% |
ADMA Biologics, Inc. ADMA Biologics, Inc. | EC | 198,116 | $3.1M | 2.21% |
Corcept Therapeutics Inc. Corcept Therapeutics Inc. | EC | 77,929 | $2.8M | 1.99% |
Prestige Consumer Healthcare Inc. Prestige Consumer Healthcare Inc. | EC | 40,026 | $2.8M | 1.98% |
Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals, Inc. | EC | 47,731 | $2.6M | 1.87% |
Acadia Pharmaceuticals Inc. Acadia Pharmaceuticals Inc. | EC | 104,215 | $2.6M | 1.83% |
Integer Holdings Corp. Integer Holdings Corp. | EC | 29,166 | $2.5M | 1.81% |
Waystar Holding Corp. Waystar Holding Corp. | EC | 95,555 | $2.5M | 1.75% |
Veracyte, Inc. Veracyte, Inc. | EC | 65,802 | $2.4M | 1.72% |
Concentra Group Holdings Parent, Inc. Concentra Group Holdings Parent, Inc. | EC | 99,223 | $2.4M | 1.70% |
Privia Health Group, Inc. Privia Health Group, Inc. | EC | 96,246 | $2.3M | 1.64% |
Catalyst Pharmaceuticals, Inc. Catalyst Pharmaceuticals, Inc. | EC | 96,176 | $2.2M | 1.59% |
Neogen Corp. Neogen Corp. | EC | 180,885 | $2.0M | 1.45% |
Amneal Pharmaceuticals, Inc. Amneal Pharmaceuticals, Inc. | EC | 141,309 | $2.0M | 1.40% |
LeMaitre Vascular, Inc. LeMaitre Vascular, Inc. | EC | 17,373 | $1.9M | 1.34% |
Acadia Healthcare Co., Inc. Acadia Healthcare Co., Inc. | EC | 76,798 | $1.8M | 1.29% |
Apellis Pharmaceuticals, Inc. Apellis Pharmaceuticals, Inc. | EC | 85,312 | $1.8M | 1.28% |
National HealthCare Corp. National HealthCare Corp. | EC | 10,332 | $1.7M | 1.21% |
Organon & Co. Organon & Co. | EC | 216,416 | $1.6M | 1.13% |
Addus HomeCare Corp. Addus HomeCare Corp. | EC | 15,183 | $1.6M | 1.12% |
Omnicell, Inc. Omnicell, Inc. | EC | 37,356 | $1.5M | 1.10% |
Perrigo Co. PLC Perrigo Co. PLC | EC | 114,562 | $1.5M | 1.08% |
Vericel Corp. Vericel Corp. | EC | 42,099 | $1.5M | 1.07% |
Sarepta Therapeutics, Inc. Sarepta Therapeutics, Inc. | EC | 87,227 | $1.5M | 1.05% |
Arcus Biosciences, Inc. Arcus Biosciences, Inc. | EC | 71,067 | $1.4M | 1.04% |
Tandem Diabetes Care, Inc. Tandem Diabetes Care, Inc. | EC | 56,440 | $1.4M | 1.02% |
Inspire Medical Systems, Inc. Inspire Medical Systems, Inc. | EC | 22,010 | $1.4M | 1.02% |
Pediatrix Medical Group, Inc. Pediatrix Medical Group, Inc. | EC | 70,074 | $1.4M | 1.00% |
Select Medical Holdings Corp. Select Medical Holdings Corp. | EC | 91,731 | $1.4M | 0.98% |
Innoviva, Inc. Innoviva, Inc. | EC | 59,127 | $1.4M | 0.97% |
UFP Technologies, Inc. UFP Technologies, Inc. | EC | 6,419 | $1.4M | 0.97% |
CorVel Corp. CorVel Corp. | EC | 26,022 | $1.3M | 0.96% |
Artivion, Inc. Artivion, Inc. | EC | 34,704 | $1.3M | 0.96% |
QuidelOrtho Corp. QuidelOrtho Corp. | EC | 56,548 | $1.3M | 0.92% |
Enovis Corp. Enovis Corp. | EC | 47,605 | $1.2M | 0.87% |
CONMED Corp. CONMED Corp. | EC | 25,779 | $1.2M | 0.85% |
Progyny, Inc. Progyny, Inc. | EC | 66,741 | $1.2M | 0.84% |
ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. | EC | 14,965 | $1.1M | 0.79% |
Collegium Pharmaceutical, Inc. Collegium Pharmaceutical, Inc. | EC | 26,314 | $1.1M | 0.78% |
NeoGenomics, Inc. NeoGenomics, Inc. | EC | 107,706 | $1.1M | 0.76% |
U.S. Physical Therapy, Inc. U.S. Physical Therapy, Inc. | EC | 12,657 | $1.1M | 0.75% |
Harmony Biosciences Holdings, Inc. Harmony Biosciences Holdings, Inc. | EC | 33,081 | $944,132 | 0.68% |
Phibro Animal Health Corp., Class A Phibro Animal Health Corp., Class A | EC | 17,021 | $929,176 | 0.66% |
Azenta, Inc. Azenta, Inc. | EC | 33,961 | $916,268 | 0.66% |
Fortrea Holdings Inc. Fortrea Holdings Inc. | EC | 76,916 | $824,540 | 0.59% |
STAAR Surgical Co. STAAR Surgical Co. | EC | 41,406 | $823,979 | 0.59% |
AdaptHealth Corp. AdaptHealth Corp. | EC | 89,332 | $817,388 | 0.58% |
BioLife Solutions, Inc. BioLife Solutions, Inc. | EC | 32,464 | $785,629 | 0.56% |
Pacira Biosciences, Inc. Pacira Biosciences, Inc. | EC | 35,812 | $784,641 | 0.56% |
Xencor, Inc. Xencor, Inc. | EC | 59,443 | $759,087 | 0.54% |
Astrana Health, Inc. Astrana Health, Inc. | EC | 35,914 | $730,132 | 0.52% |
Vir Biotechnology, Inc. Vir Biotechnology, Inc. | EC | 78,752 | $715,856 | 0.51% |
Certara, Inc. Certara, Inc. | EC | 99,437 | $704,014 | 0.50% |
Integra LifeSciences Holdings Corp. Integra LifeSciences Holdings Corp. | EC | 55,762 | $634,572 | 0.45% |
AMN Healthcare Services, Inc. AMN Healthcare Services, Inc. | EC | 31,977 | $622,912 | 0.45% |
Amphastar Pharmaceuticals, Inc. Amphastar Pharmaceuticals, Inc. | EC | 29,453 | $595,834 | 0.43% |
Schrodinger, Inc. Schrodinger, Inc. | EC | 46,712 | $563,347 | 0.40% |
Avanos Medical, Inc. Avanos Medical, Inc. | EC | 38,641 | $544,838 | 0.39% |
Embecta Corp. Embecta Corp. | EC | 48,684 | $499,498 | 0.36% |
HealthStream, Inc. HealthStream, Inc. | EC | 19,757 | $419,441 | 0.30% |
Cytek Biosciences, Inc. Cytek Biosciences, Inc. | EC | 91,537 | $410,086 | 0.29% |
Myriad Genetics, Inc. Myriad Genetics, Inc. | EC | 77,594 | $357,708 | 0.26% |
Invesco Government & Agency Portfolio, Institutional Class Invesco Government & Agency Portfolio, Institutional Class | STIV | 13,490 | $13,490 | 0.01% |
OmniAb, Inc., Rts., expiring 2027-11-02 OmniAb, Inc., Rts., expiring 2027-11-02 | EC | 20,053 | $0 | 0.00% |
OmniAb, Inc., Rts., 2027-11-02 OmniAb, Inc., Rts., 2027-11-02 | EC | 20,053 | $0 | 0.00% |